FirstView Barriers - An Analysis of Market Barriers in Multiple Sclerosis (US)
|是多發性硬化症市場上市場障礙分析 (美國的情況) FirstView Barriers - An Analysis of Market Barriers in Multiple Sclerosis (US)|
|出版日期: 2015年03月31日||內容資訊: 英文||
本報告提供美國的多發性硬化症的治療藥的市場上市場進入障礙的影響度相關分析、目前市場規模、用戶基礎，及整體市場的進入障礙 (價格、利用可能性、醫療費償付情形等) 的影響度、各企業/品牌藥由於障礙獲得、損失的市場佔有率的大小等調查、考察。
FirstView Barriers - An Analysis of Market Barriers in Multiple Sclerosis (US) provides cutting edge, advanced and proprietary analytics that companies operating in the MS space need to develop, shape and refine brand strategy. FirstView's Market Barriers in MS Report (EU5) is also available.
Critically, the report quantifies the impact and influence of specific environmental barriers - such as price, availability and reimbursement - in relation to how much market share your brand gains and loses, to which brands your share is going to, and from which brands your brand is getting share from.
The proprietary barrier instrument utilizes statistical analysis and advanced calculation to provide you with this precise information. This information allows you to act strategically and focus on the market barriers that can drive market share gains and improve competitiveness for your brand.
FirstView's Market Barriers in MS Report (EU5) is available. If you purchase both the US/EU5 reports you receive an US/EU5 Comparison Review.